We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

HUMAN GMBH

HUMAN offers a broad portfolio of in vitro diagnostic products with more than 400 products in 12 areas covering the w... read more Featured Products: More products

Download Mobile App





HUMAN Diagnostics Showcases Innovative FIA and Hematology Solutions

By LabMedica International staff writers
Posted on 24 Jul 2023

HUMAN Diagnostics (Wiesbaden, Germany), a leading global provider of in-vitro diagnostic solutions, is participating in the 2023 AACC Clinical Lab Expo taking place from July 25th to 27th in Anaheim, CA, USA. More...

As a prominent exhibitor, HUMAN is located at Booth #921, where the company is showcasing its cutting-edge products and engaging with industry professionals, researchers, and healthcare experts. The company's presence at the expo reaffirms its commitment to delivering high-quality diagnostic solutions that contribute to advancing patient care and laboratory excellence.

Among the products being featured at the exhibition is the HumaCount 5D CRP, an innovative hematology analyzer that provides rapid and precise measurement of C-reactive protein (CRP), a crucial biomarker for inflammation assessment. With its advanced technology and user-friendly interface, HumaCount 5D CRP delivers reliable results and enhances laboratory efficiency. Also being highlighted at the show is the HumaNex A1c Variant which offers a breakthrough in glycated hemoglobin (A1c) testing. This fully automated assay delivers accurate results for A1c testing, even in the presence of hemoglobin variants, ensuring reliable diabetes management and monitoring.

The company is also highlighting the HumaFIA system, a high-performance fluorescence immunoassay analyzer designed for rapid and sensitive measurement of various analytes. With its versatility and efficiency, HumaFIA facilitates precise diagnostics across a wide range of applications. At the event, HUMAN's team of experts is available to discuss the company's comprehensive product portfolio, provide demonstrations, and answer any questions from attendees.

"We are excited to participate in the prestigious AACC Clinical Lab Expo and present our latest advancements in diagnostic solutions," said Thomas Roesser, Vice President International Sales. "At HUMAN, we are dedicated to developing innovative products that empower healthcare professionals to make informed decisions and improve patient outcomes."

Related Links:
HUMAN Diagnostics 


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
HAV Rapid Test
OnSite HAV IgG/IgM Rapid Test
New
Whole Blood Control
Lyphochek Whole Blood Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.